Virios Therapeutics Announces Third Quarter 2022 Financial Results and Provides Corporate Update

Go back to Virios Therapeutics Announces Third Quarter 2022 Financial Results and Provides Corporate Update

Virios Therapeutics (VIRI) Tops Q3 EPS by 18c

November 14, 2022 7:23 AM EST

Virios Therapeutics (NASDAQ: VIRI) reported Q3 EPS of ($0.28), $0.18 better than the analyst estimate of ($0.46).

For earnings history and earnings-related data on Virios Therapeutics (VIRI) click here.

... More